Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Fexaclear
Active Ingredient: Fexofenadine hydrochloride 120mg
Dosage Form: Film coated tablet
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Medreich Limited, Bangalore, India
   
Product: Fexaclear
Active Ingredient: Fexofenadine hydrochloride 180mg
Dosage Form: Film coated tablet
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Medreich Limited, Bangalore, India
   
Product: Gabapentin
Active Ingredient: Gabapentin 100mg
Dosage Form: Capsule
New Zealand Sponsor: Max Health Limited
Manufacturer: Rivopharm SA, Manno, Switzerland
   
Product: Gabapentin
Active Ingredient: Gabapentin 300mg
Dosage Form: Capsule
New Zealand Sponsor: Max Health Limited
Manufacturer: Rivopharm SA, Manno, Switzerland
   
Product: Gabapentin
Active Ingredient: Gabapentin 400mg
Dosage Form: Capsule
New Zealand Sponsor: Max Health Limited
Manufacturer: Rivopharm SA, Manno, Switzerland
   
Product: Paracetamol Soft Gel Caps (General sale)
Active Ingredient: Paracetamol 500mg
Dosage Form: Soft gelatin capsule
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: XL Laboratories Pvt. Limited, Neemrana, India
   
Product: Paracetamol Soft Gel Caps (Pharmacy only)
Active Ingredient: Paracetamol 500mg
Dosage Form: Soft gelatin capsule
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: XL Laboratories Pvt. Limited, Neemrana, India
   
Product: Sitagliptin Sandoz
Active Ingredient: Sitagliptin hydrochloride monohydrate 28.343mg equivalent to sitagliptin 25mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Sandoz New Zealand Limited
Manufacturer: Novartis Pharmaceutical Manufacturing LLC, Ljubljana, Slovenia
   
Product: Sitagliptin Sandoz
Active Ingredient: Sitagliptin hydrochloride monohydrate 56.685mg equivalent to sitagliptin 50mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Sandoz New Zealand Limited
Manufacturer: Novartis Pharmaceutical Manufacturing LLC, Ljubljana, Slovenia
   
Product: Sitagliptin Sandoz
Active Ingredient: Sitagliptin hydrochloride monohydrate 113.37mg equivalent to sitagliptin 100mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Sandoz New Zealand Limited
Manufacturer: Novartis Pharmaceutical Manufacturing LLC, Ljubljana, Slovenia


Dated this 7th day of June 2024.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).